The startup will also use its generative AI technology to optimize manufacturing of the gene therapy, leveraging data that MeiraGTx has amassed over the course of nearly a decade developing its ...
Pharmaceutical Technology on MSN7d
MeiraGTx and Hologen launch AI-backed gene therapy ventureThe venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase III trials with up to $430m in funding from ...
Dalip Sethi provides valuable insights on how AI is currently being carefully and critically considered within the cell and ...
Using gene editing with CRISPR-Cas9, the team has been able to study these proteins without altering ... Dec. 13, 2024 — Microorganisms produce a wide variety of natural products that can be ...
News Nation on MSN12d
How genomics and AI could help treat cancer more effectivelyThese discoveries highlight how genetic profiling can play a crucial role in personalizing cancer care,” Ruishan Liu said in ...
GeneDx will present the AI-powered decision support tool at ACMG, in a session: Multiscore, a Gene Ranker Powered by Artificial Intelligence and Real-World Clinical Data, Shows High Sensitivity in ...
company specialising in multimodal generative AI models, to advance its Parkinson’s disease gene therapy programme. Hologen has committed up to $430m in funding to support the development and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback